Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells

被引:25
作者
Liu Ran-Lu [1 ]
Zhang Zhi-Hong [1 ]
Zhao Wei-Ming [1 ]
Wang Meng [1 ]
Qi Shi-Yong [1 ]
Li Jing [1 ]
Zhang Yue [1 ,2 ]
Li Sheng-Zhi [1 ,2 ]
Xu Yong [1 ]
机构
[1] Tianjin Med Univ, Hosp 2, Dept Urol, Tianjin Inst Urol, Tianjin 300211, Peoples R China
[2] Tianjin Int Urol, Tianjin 300211, Peoples R China
关键词
nucleostemin; prostatic neoplasms; PC-3; RNA interference;
D O I
10.1097/00029330-200802020-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Nucleostemin is essential for the proliferation and survival of stem and cancer cells, but it is unknown whether this newly identified molecule is involved in prostate cancer pathogenesis. Methods Total RNA and protein were extracted from prostate cancer tissues and PC-3, LNCap and DU145 cell lines. The nucleostemin mRNA and protein expression were measured by RT-PCR and Western blot. Immunohistochemistry was also used to detect the nucleostemin protein expression in prostate cancer tissues and PC-3 cells. A nucleostemin specific, short hairpin RNA, expression plasmid was used to transfect PC-3 cells. The changes of nucleostemin gene were detected and the proliferative capacity of the cells was determined. Results Nucleostemin was highly expressed in prostate cancer tissues and cell lines. Nucleostemin expression level in the silencer group PC-3 cells remarkably reduced. The proliferation rate of silencer group PC-3 cells decreased and the percentage of G1 stage cells increased. The neoplasm forming capacity in nude mice of the silencer group PC-3 cells decreased significantly. Conclusions Nucleostemin is highly expressed in prostate cancer tissues and cell lines. The proliferative capacity of PC-3 cells is remarkably reduced after silencing nucleostemin gene expression.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 19 条
[1]   A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA [J].
CRAWFORD, ED ;
EISENBERGER, MA ;
MCLEOD, DG ;
SPAULDING, JT ;
BENSON, R ;
DORR, FA ;
BLUMENSTEIN, BA ;
DAVIS, MA ;
GOODMAN, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) :419-424
[2]   Nucleostemin mRNA is expressed in both normal and malignant renal tissues [J].
Fan, Y. ;
Liu, Z. ;
Zhao, S. ;
Lou, F. ;
Nilsson, S. ;
Ekman, P. ;
Xu, D. ;
Fang, X. .
BRITISH JOURNAL OF CANCER, 2006, 94 (11) :1658-1662
[3]   Cancer statistics, 2006 [J].
Jemal, A ;
Siegel, R ;
Ward, E ;
Murray, T ;
Xu, JQ ;
Smigal, C ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) :106-130
[4]  
Liu SJ, 2004, WORLD J GASTROENTERO, V10, P1246
[5]   Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B′ regulatory subunits of protein phosphatase 2A in mice [J].
Martens, E ;
Stevens, I ;
Janssens, V ;
Vermeesch, J ;
Götz, J ;
Goris, J ;
Van Hoof, C .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 336 (04) :971-986
[6]   IDENTIFICATION OF A NEW FAMILY OF PROTEIN PHOSPHATASE 2A REGULATORY SUBUNITS [J].
MCCRIGHT, B ;
VIRSHUP, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26123-26128
[7]   Assignment of human protein phosphatase 2A regulatory subunit genes B56 alpha, B56 beta, B56 gamma, B56 delta, and B56 epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2->p12 [J].
McCright, B ;
Brothman, AR ;
Virshup, DM .
GENOMICS, 1996, 36 (01) :168-170
[8]   Going in GTP cycles in the nucleolus [J].
Misteli, T .
JOURNAL OF CELL BIOLOGY, 2005, 168 (02) :177-178
[9]   Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus [J].
Rubbi, CP ;
Milner, J .
ONCOGENE, 2000, 19 (01) :85-96
[10]  
Sijin L, 2004, J EXP CLIN CANC RES, V23, P529